Johnson & Johnson has been named the most effective pharmaceutical company on social media, in a new report.
A government-appointed panel in India is preparing to evaluate more patented drugs for local generic pharmaceutical companies to mimic, according to reports.
Pharmaceutical company Novo Nordisk has left a group of pharmaceutical companies that are unhappy with proposed drug laws in South Africa.
Teva has agreed to acquire pharmaceutical company NuPathe for $144 million.
The US Supreme Court has ruled that when licensees seek a declaratory judgement of non-infringement, the patentee bears the burden of proof to show infringement.
On January 17, Actavis confirmed that the US District Court for the District of New Jersey found its US patent 7,704,984, which covers Lo Loestrin Fe birth control pills, to be valid and infringed by Lupin and Amneal.
The US Court of Appeals for the Federal Circuit has upheld a ruling which found that the US Patent and Trademark Office had been incorrectly calculating Patent Term Adjustment lengths.
Aurobindo’s European subsidiary is set to acquire Actavis’s commercial generic operations in seven Western European markets in a deal worth about €30 million ($40 million).
South African drug companies have been accused by advocacy organisations of planning a "deceptive" campaign to delay new laws which could see the introduction of more generic medicines.
UK IP firm HGF Limited has appointed Stephanie Loeffler as a partner in its London office.